<DOC>
	<DOC>NCT01393860</DOC>
	<brief_summary>The purpose of this study is to evaluate real-world patterns of aliskiren use with a focus of change in renal function following aliskiren initiation as well as to identify "triggering events" that lead to aliskiren initiation.</brief_summary>
	<brief_title>Real-world Aliskiren Use in Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Type 2 diabetes Patients ages 18 yeras and older Hypertension Diagnosis Currently on at least 1 hypertensive medication At least 2 lab measure before and after aliskiren initiation Inadequate chart records where microalbuminuria, serum creatinine and blood pressure data are not within 312 months prior to initiation of Aliskiren Pregnancy Development of secondary renal disease unrelated to diabetes (such as nephritis) Terminal illness AIDS/HIV Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>aliskiren</keyword>
	<keyword>hypertension</keyword>
	<keyword>renal impairment</keyword>
</DOC>